Literature DB >> 3766312

The cored sponge model of in vivo leucocyte chemotaxis.

D M Mellor, D B Myers, V S Chadwick.   

Abstract

A method has been developed for the in vivo measurement of leucocyte chemotaxis in response to the bacterial chemotactic peptide F-met-leu-phe (FMLP). Polyurethane sponges were pre-treated with FMLP and implanted subcutaneously in rats and after a suitable interval removed for determination of leucocyte influx. In vivo concentration gradients of chemotactic factors within intact sponges were shallow and leucocyte accumulation unsatisfactory. Accordingly a cored sponge model was developed in which the cylindrical core only was treated with chemotactic factor and the sponge reassembled prior to subcutaneous implantation. Steep concentration gradients were established within the outer sponge matrix with marked effects on leucocyte accumulation, permitting studies of the time course of in vivo chemotaxis. With cored sponges test to control cell number ratios were maximal at 4 hours using both free and albumin-bound FMLP. This model of in vivo chemotaxis may prove useful in several areas of inflammation research.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766312     DOI: 10.1007/bf01964963

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

1.  Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnated with dead tubercle bacilli.

Authors:  A K Clarke; B Vernon-Roberts; H L Currey
Journal:  Ann Rheum Dis       Date:  1975-08       Impact factor: 19.103

Review 2.  Leukocyte chemotaxis.

Authors:  E Schiffmann
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

3.  Anisakis and eosinophil. II. Eosinophilic phlegmon experimentally induced in normal rabbits by parasite-derived eosinophil chemotactic factor (ECF-P).

Authors:  K Iwasaki; M Torisu
Journal:  Clin Immunol Immunopathol       Date:  1982-06

4.  Effects of F-met-leu-phe and zymosan-activated serum on rat neutrophils in vivo.

Authors:  R B Gilbertsen; G W Carter; D J Quinn
Journal:  J Reticuloendothel Soc       Date:  1980-05

5.  Chemotaxis of neutrophil leukocytes towards substratum-bound protein attractants.

Authors:  P C Wilkinson; R B Allan
Journal:  Exp Cell Res       Date:  1978-12       Impact factor: 3.905

6.  Inhibition of rabbit neutrophil lysosomal enzyme secretion, non-stimulated and chemotactic factor stimulated locomotion by nordihydroguaiaretic acid.

Authors:  H J Showell; P H Naccache; R I Sha'afi; E L Becker
Journal:  Life Sci       Date:  1980-08-04       Impact factor: 5.037

7.  Adhesion and the locomotion of neutrophils on surfaces and in matrices.

Authors:  J M Lackie; A F Brown
Journal:  Agents Actions Suppl       Date:  1983

8.  The mechanism of action of a single dose of methylprednisolone on acute inflammation in vivo.

Authors:  S L Wiener; R Wiener; M Urivetzky; S Shafer; H D Isenberg; C Janov; E Meilman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

Review 10.  Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe.

Authors:  J I Gallin; B E Seligmann; M P Fletcher
Journal:  Agents Actions Suppl       Date:  1983
View more
  3 in total

1.  Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model.

Authors:  J S Fine; J V Jackson; A Rojas-Triana; L A Bober
Journal:  Inflammation       Date:  2000-08       Impact factor: 4.092

2.  Partial purification and characterization of a formylmethionine deformylase from rat small intestine.

Authors:  M F Broom; R M Sherriff; W P Tate; J Collings; V S Chadwick
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

3.  A Haptotaxis Assay for Neutrophils using Optical Patterning and a High-content Approach.

Authors:  Joannie Roy; Javier Mazzaferri; János G Filep; Santiago Costantino
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.